Mistral AI Explores InHouse Chip Design to Strengthen Infrastructure Amid AI Race Expected Value Approach May Boost Predictive AI Returns Fraud Detection Illustrates Wall Street Extends Winning Streak as Consumer Sentiment Wanes Ross Stores Posts Strong Earnings Marvell Stock Slides Despite Exceptional AI Demand and Upbeat Growth Forecast Iraqs Air Power Maintenance Challenges Point to Persistent Defense Sector Reliance PutinXi Talks Set to Revive Stalled Power of Siberia 2 Pipeline as Iran Conflict Ripples Through Energy Markets GIB Q1 2026 Earnings EPS Misses Estimates Amid Disciplined Execution CCL Q1 2026 Earnings Cruise Operator Beats EPS Expectations Despite Market Pullback TRIP Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Uncertainty SRTA Q1 2026 Earnings Profit Surprise as Company Outpaces Estimates Okta Inc OKTA Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Revenue Ambiguity Bridgewater Bancshares Inc BWB Q1 2026 Earnings EPS Falls Short of Consensus by Narrow Margin Allarity Therapeutics ALLR Surges 66 as Volume Picks Up Testing Key Resistance Micron Technology MU Surges 1929 Momentum Builds Above Key Support Polar Power Inc POLA Slips 619 as Shares Approach Key Support Level Eaton Corporation ETN Dips 113 as Support Levels Come into View Innoviz Technologies INVZ Rebounds from Key Support Is a Trend Reversal Brewing Info Edge Shares Dip 4 Despite Strong 22 Rise in Q4 Net Profit and 16 Revenue Growth MUX Q1 2026 Earnings EPS Surges Past Estimates by 58 Despite Revenue Disconnect Brookfield Infrastructure Partners BIP Slips 182 as It Approaches Key Support Level ORKT Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines UPS Q1 2026 Earnings EPS Beat Lifts Stock Amid Mixed Operating Environment HOUR Q4 2024 Earnings Loss Per Share of 004 Reported Amid Quiet Trading CMS Energy Q1 2026 Earnings EPS Beats Estimates Amid Solid Utility Performance MaxCyte MXCT Q1 2026 Earnings EPS Surprises Positively on LowerThanExpected Loss Revenue Not Disclosed ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending JOYY Q4 2025 Earnings EPS Falls Short of Estimates Stock Declines